Kjeldsen SE - Search Results

1

Hypertension: When should we treat hypertension in patients with diabetes?

Kjeldsen SE, Os I. Kjeldsen SE, et al. Nat Rev Cardiol. 2016 May;13(5):252-3. doi: 10.1038/nrcardio.2016.49. Epub 2016 Apr 7. Nat Rev Cardiol. 2016. PMID: 27053453 No abstract available.

2

Lower plasma noradrenaline and blood viscosity on carvedilol vs atenolol in men with recent myocardial infarction.

Jonsson G, Fossum E, Kjeldsen SE, Høieggen A, Os I, Eide I, Westheim A. Jonsson G, et al. Among authors: kjeldsen se. Blood Press. 2002;11(6):377-84. doi: 10.1080/080370502321095357. Blood Press. 2002. PMID: 12523682 Clinical Trial.

3

Hypertension in very old people.

Kjeldsen SE, Os I. Kjeldsen SE, et al. J Hypertens. 2003 Dec;21(12):2249-50. doi: 10.1097/00004872-200312000-00011. J Hypertens. 2003. PMID: 14654743 No abstract available.

4

Hypertension treatment and stroke prevention.

Kjeldsen SE, Fossum E, Reims HM, Høieggen A. Kjeldsen SE, et al. Blood Press. 2003;12(5-6):264-8. doi: 10.1080/08037050310016501. Blood Press. 2003. PMID: 14763656 Review. No abstract available.

5

Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

Kjeldsen SE, Julius S. Kjeldsen SE, et al. Am Heart J. 2004 Nov;148(5):747-54. doi: 10.1016/j.ahj.2004.04.037. Am Heart J. 2004. PMID: 15523303 Review.

6

Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide.

Kjeldsen SE, Os I, Høieggen A, Beckey K, Gleim GW, Oparil S. Kjeldsen SE, et al. Am J Cardiovasc Drugs. 2005;5(1):17-22. doi: 10.2165/00129784-200505010-00003. Am J Cardiovasc Drugs. 2005. PMID: 15631534 Review.

7

Renal hypertensive target organ damage--new evidence emerges in diabetics and smokers.

Kjeldsen SE, Os I, Hedner T, Himmelmann A. Kjeldsen SE, et al. Blood Press. 2004;13(6):324-5. doi: 10.1080/08037050410010416. Blood Press. 2004. PMID: 15771214 No abstract available.

8

A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients.

Jonsson G, Abdelnoor M, Müller C, Kjeldsen SE, Os I, Westheim A. Jonsson G, et al. Among authors: kjeldsen se. Cardiology. 2005;103(3):148-55. doi: 10.1159/000084584. Epub 2005 Mar 21. Cardiology. 2005. PMID: 15785019 Clinical Trial.

9

The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study.

Kjeldsen SE, Lyle PA, Kizer JR, Dahlöf B, Devereux RB, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Snapinn SM, Harris KE, Wedel H; LIFE Study Group. Kjeldsen SE, et al. J Clin Hypertens (Greenwich). 2005 Mar;7(3):152-8. doi: 10.1111/j.1524-6175.2005.04254.x. J Clin Hypertens (Greenwich). 2005. PMID: 15785156 Free PMC article. Clinical Trial.

10

[Uric acid--more deleterious than we thought?].

Høieggen A, Os I, Kjeldsen SE. Høieggen A, et al. Among authors: kjeldsen se. Tidsskr Nor Laegeforen. 2005 May 19;125(10):1330-2. Tidsskr Nor Laegeforen. 2005. PMID: 15909004 Free article. Review. Norwegian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

694 results

Search Page